Arenicin

Arenicins are a group of antimicrobial peptides being studied to combat Gram-negative bacteria. The arenicin family consists of three different peptides: arenicin-1, arenicin-2, and the most recently discovered, arencin-3. Adenium Biotech currently remains in the preclinical testing period of their product, arenicin-3. Toxicology, drug efficacy, and other information have yet to be determined with further research completed in clinical settings. However, with Gram-negative bacteria causing 65% of hospital-acquired infections, the commercial market for arenicin is large.

Arenicin

Arenicins are a group of antimicrobial peptides being studied to combat Gram-negative bacteria. The arenicin family consists of three different peptides: arenicin-1, arenicin-2, and the most recently discovered, arencin-3. Adenium Biotech currently remains in the preclinical testing period of their product, arenicin-3. Toxicology, drug efficacy, and other information have yet to be determined with further research completed in clinical settings. However, with Gram-negative bacteria causing 65% of hospital-acquired infections, the commercial market for arenicin is large.